Medical device maker ICU Medical changed the designs of infusion pumps made in Minnesota without properly clearing important regulatory checks after a recent recall, according to a Food and Drug ...

About the Artificial Dye Ban. On April 22, the FDA issued a statement saying it will phase out all petroleum-based synthetic ...

The FDA plans to phase out petroleum-based food dyes, aiming to protect public health—especially children—as part of the ...

After firing several employees, FDA is planning to hire contractors in place of fired staff. The departed staffers include ...

The contractors would effectively replace most of the work done by more than 50 laid-off federal employees who handled travel ...

The U.S. Food and Drug Administration (U.S. FDA) has approved Biocon Biologics’ Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use. JOBEVNE, a recombinant humanized ...

CPHI Americas 2025, which is committed to empowering the next generation of pharmaceutical professionals, and has announced a new Emerging Professional badge, offering learning, networking, and career ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model.

Vitrakvi received full FDA approval for treating NTRK gene fusion-positive solid tumors in adults and children, following its initial accelerated approval in 2018. The drug functions as a tyrosine ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI ® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and ...

Food and Drug Administration leaders directly intervened to halt approval of a Covid-19 vaccine ... Several officials characterized FDA Commissioner Marty Makary, who signed off on the ouster ...